Voyager Therapeutics
$12.739876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$12.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.01 (-0.08%) As of 2:28 PM EST today
-$0.01 (-0.08%) Today
Why Robinhood?
You can buy or sell VYGR and other stocks, options, ETFs, and crypto commission-free!
About VYGR
Voyager Therapeutics, Inc. operates as a clinical-stage gene therapy company, which develops treatments for patients suffering from central nervous system. Its pipeline of gene theraphy programs include VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. Read More The company was founded by Guangping Gao, Mark A. Kay, Krystof Bankiewicz and Phillip Zamore in June 2013 and is headquartered in Cambridge, MA.
Employees
123
Headquarters
Cambridge, Massachusetts
Founded
2013
Market Cap
480.84M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
289.83K
High Today
$12.80
Low Today
$12.44
Open Price
$12.71
Volume
130.76K
52 Week High
$28.79
52 Week Low
$10.51
Collections
Analyst Ratings
83%
of 12 ratings
Buy
83%
Hold
17%
Sell
0%
VYGR Earnings
-$0.81
-$0.35
$0.12
$0.58
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Mar 3, After Hours
People Also Bought
Viking Therapeutics
38,964
$6.89
-1.01%CRISPR
26,938
$53.39
-5.94%AbbVie
27,255
$95.40
+1.24%Editas Medicine
10,027
$25.16
-4.33%Sangamo Therapeutics
4,932
$7.47
-0.93%Intellia Therapeutics
5,296
$13.35
-5.18%Canopy Growth
178,857
$21.90
-1.83%Cronos Group
192,183
$7.17
-2.32%Nektar Therapeutics
4,975
$23.82
+0.63%Aurora Cannabis
671,428
$1.65
-1.64%Sarepta Therapeutics
2,063
$123.76
+0.54%iQIYI
31,999